GREENSBORO, N.C., Feb. 23 /PRNewswire/ -- Neuisys Imaging System Solutions, LLC announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the NeuViz 16 Multi-Slice Computed Tomography (CT) System. The NeuViz 16 is developed by Philips Neusoft Medical Systems, a joint venture between Royal Philips Electronics of the Netherlands and Neusoft Corporation of China.
"The NeuViz 16 is a state-of-the-art CT system that provides superior performance for the price and provides the clinical benefits of routine, sub-millimeter resolution, volume imaging and low-dose protocols," said Kim Russell, Neuisys president and chief executive officer. "The NeuViz 16 packs a tremendous amount of technology into a very economical footprint and is the perfect solution for diagnostic imaging centers and community hospitals that plan to upgrade from older single or multi-slice CT systems to 16-slice CT as well as a wide array of specialist physician groups considering in-office CT including urologists, gastroenterologists, pulmonologists, surgeons, and oncologists."
"With the NeuViz 16, physician groups can now routinely provide their patients with convenient, highly advanced in-office CT imaging, shortening the stressful time between testing and diagnosis report to the patient," said Dr. Joseph Jenkins, Neuisys chief medical officer. "The NeuViz 16 provides many advanced clinical applications including CT angiography of peripheral and neuro vasculature, virtual colonoscopy, lung nodule protocols, pulmonary embolism protocols, CT urography, and tissue perfusion studies."
"We have been extremely satisfied with Neuisys and the NeuViz Dual CT
system that we installed in our practice last year and we expect that the
NeuViz 16 will have the same reliability, quality, speed, and ease-of-use with
even more performance and clinical capabilities," said Dr. Stan Sujka of
Orlando Urology A
|SOURCE Neuisys Imaging Systems Solutions, LLC|
Copyright©2009 PR Newswire.
All rights reserved